Bio-Techne Corp. (TECH)
72.44
-0.14
(-0.19%)
USD |
NASDAQ |
Oct 06, 16:00
72.44
0.00 (0.00%)
After-Hours: 19:00
Bio-Techne Free Cash Flow : 263.22M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 263.22M |
| March 31, 2026 | 269.60M |
| December 31, 2025 | 223.02M |
| September 30, 2025 | 224.06M |
| June 30, 2025 | 256.55M |
| March 31, 2025 | 220.76M |
| December 31, 2024 | 254.30M |
| September 30, 2024 | 245.03M |
| June 30, 2024 | 236.10M |
| March 31, 2024 | 251.15M |
| December 31, 2023 | 225.39M |
| September 30, 2023 | 215.42M |
| June 30, 2023 | 216.15M |
| March 31, 2023 | 232.73M |
| December 31, 2022 | 251.98M |
| September 30, 2022 | 284.52M |
| June 30, 2022 | 280.36M |
| March 31, 2022 | 301.92M |
| December 31, 2021 | 308.16M |
| September 30, 2021 | 295.16M |
| June 30, 2021 | 307.86M |
| March 31, 2021 | 224.58M |
| December 31, 2020 | 200.50M |
| September 30, 2020 | 178.53M |
| June 30, 2020 | 153.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 170.31M |
| December 31, 2019 | 164.86M |
| September 30, 2019 | 150.96M |
| June 30, 2019 | 156.21M |
| March 31, 2019 | 170.98M |
| December 31, 2018 | 154.38M |
| September 30, 2018 | 145.27M |
| June 30, 2018 | 149.43M |
| March 31, 2018 | 135.39M |
| December 31, 2017 | 138.25M |
| September 30, 2017 | 144.18M |
| June 30, 2017 | 128.54M |
| March 31, 2017 | 116.87M |
| December 31, 2016 | 130.17M |
| September 30, 2016 | 125.04M |
| June 30, 2016 | 126.97M |
| March 31, 2016 | 123.87M |
| December 31, 2015 | 115.42M |
| September 30, 2015 | 113.91M |
| June 30, 2015 | 119.45M |
| March 31, 2015 | 124.98M |
| December 31, 2014 | 129.80M |
| September 30, 2014 | 125.50M |
| June 30, 2014 | 122.88M |
| March 31, 2014 | 112.38M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Repligen Corp. | 110.15M |
| BioLife Solutions, Inc. | 7.987M |
| MindWalk Holdings Corp. | -9.062M |
| Maravai Lifesciences Holdings, Inc. | -35.11M |
| MaxCyte, Inc. | -23.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 95.42M |
| Cash from Investing (Quarterly) | -7.057M |
| Cash from Financing (Quarterly) | -33.21M |
| Free Cash Flow Per Share (Quarterly) | 0.5536 |
| Free Cash Flow to Equity (Quarterly) | 88.17M |
| Free Cash Flow to Firm (Quarterly) | 89.09M |
| Free Cash Flow Yield | 2.32% |